SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-002691
Filing Date
2023-02-14
Accepted
2023-02-14 06:25:50
Documents
13
Period of Report
2023-02-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K apgn-20230213.htm   iXBRL 8-K 55350
  Complete submission text file 0000950170-23-002691.txt   213673

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apgn-20230213.xsd EX-101.SCH 3547
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apgn-20230213_pre.xml EX-101.PRE 13266
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apgn-20230213_def.xml EX-101.DEF 13966
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT apgn-20230213_lab.xml EX-101.LAB 18314
7 EXTRACTED XBRL INSTANCE DOCUMENT apgn-20230213_htm.xml XML 6710
Mailing Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070
Business Address 75 SHOREWAY ROAD, SUITE C SAN CARLOS CA 94070 650.931.6236
Apexigen, Inc. (Filer) CIK: 0001814140 (see all company filings)

IRS No.: 851260244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39488 | Film No.: 23622012
SIC: 2834 Pharmaceutical Preparations